Over the past 30 years, the discovery of new molecules and innovative therapies has led to a rapid growth in the biopharmaceuticals market. However, the way biopharmaceuticals behave immediately after subcutaneous administration is still largely unknown. To tackle this, Pion designed Scissor in conjunction with Genentech and the University of Bath. Scissor is the first instrument to successfully simulate the stress conditions and environmental transitions a biopharmaceutical drug experiences when injected subcutaneously. And Pion’s been able to use our experience to successfully extend the application of Scissor into small molecules and peptides too.
The Pion suite of In vivo Predictive Tools works in harmony to offer you fast, accurate and cost-effective results.
Designed specifically to assess the risk and performance of subcutaneously administered drugs including biologics, peptides and small molecules.